Results for “Cancer”

The Guardian World Australian Associated Press Geopolitics

Howard-era minister Sharman Stone dies via voluntary assisted dying, aged 75

The former Liberal MP had fought a long battle against glioblastoma, an aggressive form of brain cancer Get our daily political email, free app or daily news podcast Former Liberal MP Sharman Stone has died via voluntary assisted dying after spending much of her political career advocating that people should have autonomy over their bodies. Stone died aged 75 on Wednesday surrounded by family after a long fight against glioblastoma, an aggressive form of brain cancer.

Read at The Guardian World

The Hill Ford McCracken Geopolitics

Sasse to release memoir on his life, family amid cancer battle

Former Sen. Ben Sasse (R-Neb.) announced Thursday he will release a new memoir reflecting on his life and the passage of time next year, which he penned alongside his daughter amid his battle with Stage 4 pancreatic cancer. “Fighting cancer is… uh…not as fun as you might expect, but…working on a book with your kid...

Read at The Hill

NBC News Doha Madani

Jax Taylor, former ‘Vanderpump Rules’ and Bravo reality TV star, reveals cancer diagnosis

Jax Taylor, who was made famous on the Bravo reality series “Vanderpump Rules,” shared with fans Thursday that he was recently diagnosed with cancer.

Read at NBC News

The Guardian World Tom Perkins

Trump takes 500 actions to weaken cancer protections, new report says

Natural Resources Defense Council shows how federal rules changes will increase public’s exposure to carcinogens Amid a rise in early onset cancer, the Trump administration has taken more than 500 actions to systematically dismantle protections against carcinogens once in place across the federal government, an October report alleges. The Natural Resources Defense Council report, and comments from current and former officials from the Environmental Protection Agency (EPA)…

Read at The Guardian World

STAT Biotech Adam Feuerstein

STAT+: In cancer drug development, the spotlight shifts onto Erasca’s KRAS-targeted treatment

Did the biotech company Erasca find a more potent, better-tolerated pan-RAS cancer drug than Revolution Medicines?

Read at STAT Biotech

GEN (Genetic Engineering & Biotechnology News) Julianna LeMieux, PhD

Targeting Folate Receptor Reverses Colorectal Cancer’s Resistance to Immunotherapy in Mice

Targeting FOLR1 with an approved antibody-drug conjugate restored anti-tumor immunity and enhanced anti-PD-1 effectiveness in colorectal cancer, overcoming immune evasion in mouse models.

Read at GEN (Genetic Engineering & Biotechnology News)

The Guardian World Ian Sample Science editor

Bacterial toxin produced by E coli leading suspect in rise in bowel cancer among under-50s

Scientists tell Commons exposure to colibactin in early life is potential driver of early-onset colorectal cancer Exposure to a bacterial toxin in early life has emerged as a leading suspect in the rise of bowel cancer among those under 50, MPs have heard. Cases of early-onset bowel cancer have doubled in many countries in the past two decades, and while rising obesity and a fall in physical activity are contributors, researchers believe other factors must also be involved.

Read at The Guardian World

The Guardian World Tobi Thomas Health and inequalities correspondent

Cancer patients at NHS trust harmed by years of unnecessary chemotherapy, report finds

Trust apologises after findings on treatment of 20 brain tumour patients under oncologist who retired in 2023 Cancer patients were severely harmed after being given years of unnecessary chemotherapy treatment by an NHS trust, a report has found. Some people were misdiagnosed and given inappropriate courses of treatment, while others were incorrectly told that if they stopped chemotherapy they would die, according to a Royal College of Physicians (RCP) report.

Read at The Guardian World

The Hill The Hill Staff Geopolitics

Watch live: The Promise of Early Intervention — The ASAP Act and A New Look at Life with Alzheimer’s

Today, more than 7 million Americans are living with Alzheimer’s disease — a number projected to reach more than 13 million by 2050. Each year, more Americans lose their lives to Alzheimer’s than to breast cancer and prostate cancer combined, and women bear a disproportionate share of that burden. The condition is often associated with...

Read at The Hill

STAT Biotech Elaine Chen and Adam Feuerstein

STAT+: FDA discloses reasons for rejecting Summit drug

The FDA published its complete response letter to Summit Therapeutics explaining why it rejected the biotech's closely watched lung cancer drug:

Read at STAT Biotech

South China Morning Post Lexi Tian Geopolitics

‘Felt like nothing happened’: Hongkonger lauds incision-free kidney cancer therapy

Hongkonger Li Sing-yan has recalled how he “felt like nothing happened” on the day he became one of Asia’s first two kidney cancer patients to receive an incision-free procedure that left him with no wounds or pain, enabling him to eat normal meals by that evening. The cutting-edge technique, called histotripsy, uses focused sound waves to break apart tumours without surgical incisions. The non-invasive medical procedure has already been used to treat more than 400 patients…

Read at South China Morning Post

The Guardian World Martin Pengelly Geopolitics

Joe Biden criticizes Zelenskyy as ‘moody’ and ‘not as grateful’ in new memoir

Promise Me, America was published just before the former US president’s 84th birthday as he battles advanced cancer In a new memoir, Joe Biden offers harsh criticism of Volodymyr Zelenskyy, who has led Ukraine through four-and-a-half years of war against Russia. According to Biden, the Ukrainian president was “difficult to work with”, “moody and stubborn in our private conversations”, and “not as grateful as I expected” for US diplomatic support and military aid. Biden’s…

Read at The Guardian World

BioPharma Dive Delilah Alvarado

Roche breast cancer pill cleared by FDA

Wilserdly’s U.S. approval is seen by analysts as a “key first step” in an important launch for Roche, which has claimed the drug could become its top-selling product.

Read at BioPharma Dive

STAT Biotech Adam Feuerstein

STAT+: Sellas’ experimental blood cancer immunotherapy reduced risk of death in clinical trial

Sellas' experimental blood cancer immunotherapy reduced the risk of death in clinical trial.

Read at STAT Biotech

Sixth Tone Chen Yiru

China’s Basic Insurance to Cover CAR T-Cell Cancer Therapy

The treatment, which involves modifying a patient’s own cells to fight blood cancer, will be eligible for partial reimbursement beginning Jan. 1.

Read at Sixth Tone

South China Morning Post Lexi Tian Geopolitics

Top Chinese cancer researcher calls on Hong Kong to deepen research ties with mainland

A leading Chinese blood cancer specialist has urged Hong Kong to deepen research collaboration with mainland China, saying the city could play a unique role in connecting the mainland’s growing scientific capabilities with the international life sciences community. Zhu Chen, a professor at Ruijin Hospital of Shanghai Jiao Tong University’s school of medicine, received the 2026 Shaw Prize in Life Science and Medicine last week alongside French molecular biologist Anne Dejean…

Read at South China Morning Post

BioPharma Dive Jonathan Gardner

Summit shares fall as FDA rejects closely watched PD-1/VEGF drug

The FDA refused to overlook ivonescimab’s failure to initially extend survival in a form of lung cancer, setting back Summit’s first chance to win a U.S. approval.

Read at BioPharma Dive

BioPharma Dive Ben Fidler

CG Oncology drug delivers ‘exceptional’ results in key bladder cancer trial

CG’s therapy cretostimogene cut the risk of recurrence by 68% when administered after surgery, far surpassing Wall Street’s expectations and lifting company shares.

Read at BioPharma Dive

STAT Biotech Adam Feuerstein

STAT+: Bladder cancer immunotherapy from CG Oncology reduced risk of tumor recurrence

CG Oncology's bladder cancer immunotherapy reduced risk of tumor recurrence by 68% — results that may change how physicians treat certain patients.

Read at STAT Biotech

Viet Nam News (state-run daily)

Immunotherapy expands approaches for treating cancers commonly affecting women

Advances in understanding tumor biology, immunotherapy and biomarkers are progressively transforming cancer treatment approaches, providing a stronger scientific basis for selecting treatment strategies tailored to each patient.

Read at Viet Nam News (state-run daily)

VnExpress International

Vietnam cancer deaths surge 2.4-fold in 5 years, lung cancer leads fatalities

Vietnam recorded 46,800 cancer deaths in 2025, more than 2.4 times the figure in 2021, with lung cancer emerging as the leading cause.

Read at VnExpress International

South China Morning Post Xinmei Shen Geopolitics

Akeso shares plummet as Chinese firm’s cancer drug ivonescimab faces FDA setback

Shares in Hong Kong-listed Akeso plunged as much as 31.8 per cent on Monday morning after the US Food and Drug Administration (FDA) rejected its cancer drug application, raising investor worries over the company’s near-term commercial outlook. Ivonescimab, one of the most closely watched innovative drugs emerging from China, did not establish “substantial evidence of effectiveness”, said US firm Summit Therapeutics, which has the exclusive rights to develop and commercialise…

Read at South China Morning Post

The New York Times Asia Rebecca Robbins

F.D.A. Rejects Closely Watched Lung Cancer Drug From China

The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.

Read at The New York Times Asia

South China Morning Post Agence France-Presse Geopolitics

Pope Leo visits high Andes, testing recovery from lung cancer surgery

Pope Leo on Sunday faced his toughest physical test since undergoing lung cancer surgery, visiting high-altitude Cusco on the final full day of his South America tour. The 71-year-old pontiff, who had part of a lung removed a month ago, arrived in the ancient Inca capital, more than 3,400 metres (11,000ft) above sea level – high enough to leave many a visitor breathless. Children in brightly woven ponchos and embroidered skirts greeted the pope as he stepped off the plane…

Read at South China Morning Post

STAT Biotech Adam Feuerstein

STAT+: FDA rejects lung cancer treatment ivonescimab from Summit Therapeutics

The FDA has rejected ivonescimab, a treatment for a type of lung cancer developed by U.S. biotech Summit Therapeutics and the Chinese drugmaker Akeso.

Read at STAT Biotech

The Guardian World Anna Bawden

NHS England on track to miss key cancer treatment target by 10,000 patients

Exclusive: 2,850 more patients a month would need to be treated within 62 days to meet March 2027 goal, as experts warn of failure of leadership Nearly 10,000 more cancer patients in England will not be treated on time because the government will fail to meet its targets, amid a failure of leadership, focus and resource, experts have warned. The NHS set an interim target to treat 80% of cancer patients within 62 days of urgent referral or consultant upgrade by March 2027…

Read at The Guardian World

YourStory Startups

Stage III cancer to 200+ startups: How Tej Chingtham built the Northeast’s first incubator

From a push for better startup support to mentoring 200+ ventures, Prof. (Dr.) Tej Chingtham is helping shape Northeast India’s startup ecosystem through AIC-SMUTBI.

Read at YourStory

GEN (Genetic Engineering & Biotechnology News) Sophia Ktori

DCIS Cell Atlas Reveals Clues to Invasive Breast Cancer Progression

Researchers created a detailed map of the tumor microenvironment surrounding estrogen receptor-positive ductal carcinoma in situ, which may help better predict progression to invasive breast cancer and inform on future therapeutic strategies.

Read at GEN (Genetic Engineering & Biotechnology News)

BBC World Geopolitics

The Peruvian city that has embraced Pope Leo as one of its own

Pope Leo XIV is in Peru as part of his Latin America tour, just weeks after having surgery for lung cancer.

Read at BBC World

BioPharma Dive BioPharma Dive staff

Novo submits sickle cell drug; Flagship, Gates Foundation deepen ties

Novo views the medicine, acquired in a billion-dollar deal, as a future blockbuster. Meanwhile, a pair of startups forged an RNA editing pact and Astellas lined up two new trials in pancreatic cancer.

Read at BioPharma Dive

Older stories